Fungemia in a cancer patient caused by fluconazole-resistant Cryptococcus laurentii

References

• Kwon-Chung KJ, Bennett JE. Cryptococcosis. In: Kwon-Chung KJ, Bennett JE, eds. Medical Mycology. Philadelphia: Lea and Febiger, 1992: 397–446.
   Google Scholar
• Mitchell T, Perfect J. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Gun Micro biol Rev 1995; 8: 515–548.
   Web of Science ®Google Scholar
• Casadevall A, Perfect J. Cryptococcus neofotmans. Washington, DC: ASM Press, 1998.
   Google Scholar
• Diamond R, Bennett J. Prognostic factors in cryptococcal meningitis: a study of 111 cases. Ann Intern Med 1974; 80: 176–181.
   PubMed Web of Science ®Google Scholar
• Kamalam A, Yesudian P, Thambiah AS. Cutaneous infection by Cryptococcus laurentii. Br J Dermatol 1977; 97: 221–223.
   PubMed Web of Science ®Google Scholar
• Krcmery V, Jr., Kunova A, Mardiak J. Nosocomial Cryptococ-cus laurentii fungemia in a bone marrow transplant patient after prophylaxis with ketoconazole successfully treated with oral fluconazole. Infection 1997; 25: 130.
   PubMed Web of Science ®Google Scholar
• Kordossis T, Avlami A, Velegraki A, et al. First report of Cryptococcus laurentii meningitis and a fatal case of Crypto-coccus albidus cryptococcaemia in AIDS patients. Med Mycol 1998; 36: 335–339.
   PubMed Web of Science ®Google Scholar
• Johnson LB, Bradley SF, Kauffman CA. Fungaemia due to Cryptococcus laurentii and a review of non-neofotmans crypto-coccaemia. Mycoses 1998; 41: 277–280.
   Google Scholar
• Cheng MF, Chiou CC, Liu YC, et al. Cryptococcus laurentii fun gemia in a premature neonate. J Gun Microbiol 2001; 39: 1608–1611.
   Web of Science ®Google Scholar
• Barnett JA, Payne RW, Yarrow D. Yeasts: Characteristics and Identification. 3rd edn. Cambridge: Cambridge University Press, 2000.
   Google Scholar
• Fell JW, Statzell-Tallman A. Cryptococcus Vuillemin. In: Kurtzman CP, Fell JW, eds. The Yeasts, A Taxonomic Study, 4th edn. Amsterdam: Elsevier, 1998: 742–767.
   Google Scholar
• Fell JW, Boekhout T, Fonseca A, et al. Biodiversity and systematics of basidiomycetous yeasts as determined by large-subunit rDNA D1/D2 domain sequence analysis. Int J Syst Evol Microbiol 2000; 50: 1351–1371.
   PubMed Web of Science ®Google Scholar
• Aller Al, Martin-Mazuelos E, Gutierrez MJ, et al. Comparison of the Etest and microdilution method for antifungal suscept-ibility testing of Cryptococcus neofotmans to four antifungal agents. J Antimicrob Chemother 2000; 46: 997–1000.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Refer-ence method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. Wayne, PA: National Committee for Clinical Laboratory Standards, 1997.
   Google Scholar
• Espinel-Ingroff A, Pfaller M, Messer SA, et al. Multicenter comparison of the sensititre YeastOne Coloiimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms. J Gun Microbio11999; 37: 591–595.
   Google Scholar
• Boekhout T, Scorzetti G, Fell JW. Phenotypic characteristics of Cryptococcus neofotmans are present in the Cryptococcus laurentii species complex. 4th International Conference on Cryptococcus and Cryptococcosis. London, 1999: 193.
   Google Scholar
• Sugita T, Takashima M, Ikeda R, et al. Intraspecies diversity of Cryptococcus laurentii as revealed by sequences of internal transcribed spacer regions and 28S rRNA gene and taxonomic position of C. laurentii clinical isolates. J Gun Microbiol 2000; 38: 1468–1471.
   PubMed Web of Science ®Google Scholar
• Mattsson R, Haemig PD, Olsen B. Feral pigeons as carriers of Cryptococcus laurentii, Cryptococcus uniguttulatus and Debar-yomyces hansenii. Med Mycol 1999; 37: 367–369.
   Google Scholar
• Krajden S, Summerbell RC, Kane J, et al. Normally saprobic cryptococci isolated from Cryptococcus neofotmans infections. J Gun Microbiol 1991; 29: 1883–1887.
   Web of Science ®Google Scholar
• Sinnott JT 4th, Rodnite J, Emmanuel PJ, et al. Oyptococcus laurentii infection complicating peritoneal dialysis. Pediatr Infect Dis J 1989; 8: 803–805.
   Google Scholar
• Lynch JP 3rd, Schaberg DR, Kissner DG, et al. Cryptococcus laurentii lung abscess. Am Rev Respir Dis 1981; 123: 135–138.
   PubMed Web of Science ®Google Scholar
• Custis PH, Haller JA, de Juan E, Jr. An unusual case of cryptococcal endophthalmitis. Retina 1995; 15: 300–304.
   PubMed Web of Science ®Google Scholar
• Mocan H, Murphy AV, Beattie TJ, et al. Fungal peritonitis in children on continuous ambulatory peritoneal dialysis. Scott Med J 1989; 34: 494–496.
   PubMed Web of Science ®Google Scholar
• Krcmery V Jr, Oravcova E, Spanik S, et al. Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome. J Antimicrob Chemother 1998; 41: 373–380.
   PubMed Web of Science ®Google Scholar
• Krcmery V Jr, Krupova I, Denning DW. Invasive yeast infections other than Candida spp. in acute leukaemia. J Hosp Infect 1999; 41: 181–194.
   Google Scholar
• Ryder NS, Wagner S, Leitner I. In vitro activities of terbinafme against cutaneous isolates of Candida albicans and other pathogenic yeasts. Antimicrob Agents Chemother 1998; 42: 1057–1061.
   Google Scholar
• Rex JH, Pfaller MA, Galgiani JN, et al. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin Infect Dis 1997; 24: 235–247.
   PubMed Web of Science ®Google Scholar
• Wasserlauf-Orni R, Izkhakov E, Siegman-Igra Y, et al. Fluco-nazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to flucona-zole. Clin Infect Dis 1999; 29: 1592–1593.
   Google Scholar
• Mondon P, Petter R, Amalfitano G, et al. Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans. Antimicrob Agents Chemother 1999; 43: 1856–1861.
   PubMed Web of Science ®Google Scholar
• Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995; 39: 1–8.
   PubMed Web of Science ®Google Scholar
• Vanden Bossche H, Dromer F, Improvisi I, et al. Antifungal drug resistance in pathogenic fungi. Med Mycol 1998; 36: 119–128.
   PubMed Web of Science ®Google Scholar